STOCK TITAN

Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024

Novavax (Nasdaq: NVAX) has announced it will report its second quarter 2024 financial results and operational highlights on August 8, 2024 at 8:30 a.m. Eastern Time.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings date

Novavax (Nasdaq: NVAX) has announced it will report its second quarter 2024 financial results and operational highlights on August 8, 2024 at 8:30 a.m. Eastern Time. The company, which focuses on advancing protein-based vaccines with its Matrix-M™ adjuvant, will host a conference call and webcast for this purpose. Participants can join via phone or webcast, with registration available through a provided URL. The call will be accessible domestically at (800) 836-8184 and internationally at (+1) (646) 357-8785. A replay will be available from 11:30 a.m. ET on August 8 until August 15, 2024, with the webcast replay extending to September 8, 2024.

Loading...
Loading translation...
Argus Session date unavailable
-1.87% session move Open Argus
Details

News Market Reaction – NVAX

The recorded move for NVAX in the trading session of this news was -1.87%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

GAITHERSBURG, Md., Aug. 1, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its second quarter 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, August 8, 2024. Details of the event and replay are as follows:

Conference call details:




Date:

August 8, 2024



Time:

8:30 a.m. U.S. ET



URL to register phone:

https://emportal.ink/3XTduSS



Dial-in number:

(800) 836-8184 (Domestic) or


(+1) (646) 357-8785 (International)



Webcast:

ir.novavax.com/events 

  • Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
  • Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
  • To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.

Replay details:




Date:

Available starting at 11:30 a.m. ET, August 8, 2024, until 11:59 p.m. U.S. ET, August 15, 2024



Dial-in number:

(888) 660-6345 (Domestic) or


(+1) (646) 517-4150 (International)



Passcode:

52500#



Webcast:

ir.novavax.com/events, until September 8, 2024

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors
Erika Schultz
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
202-709-5563
media@novavax.com

 

Novavax Logo (PRNewsfoto/Novavax)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-second-quarter-2024-financial-results-and-operational-highlights-on-august-8-2024-302212235.html

SOURCE Novavax, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Novavax (NVAX) report its Q2 2024 financial results?

Novavax (NVAX) will report its second quarter 2024 financial results and operational highlights on Thursday, August 8, 2024, at 8:30 a.m. Eastern Time.

How can investors join Novavax's (NVAX) Q2 2024 earnings call?

Investors can join Novavax's Q2 2024 earnings call by phone using the numbers (800) 836-8184 (Domestic) or (+1) (646) 357-8785 (International), or via webcast at ir.novavax.com/events. Registration is also available through a provided URL for automated callback.

Until when will the replay of Novavax's (NVAX) Q2 2024 earnings call be available?

The phone replay of Novavax's Q2 2024 earnings call will be available until August 15, 2024, while the webcast replay will be accessible until September 8, 2024.

What is the focus of Novavax's (NVAX) business?

Novavax (NVAX) is a global company advancing protein-based vaccines with its proprietary Matrix-M™ adjuvant technology.

Keep reading